We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Theradiag Acquires Prestizia and its Highly Innovative microRNA Technology Platform

News   Jun 29, 2012

 
Theradiag Acquires Prestizia and its Highly Innovative microRNA Technology Platform
 
 
 

RELATED ARTICLES

The Power of Genetic Testing – Picking Out the Best Drugs for Children With Cancer

News

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.

READ MORE

How Does Cancer Cause Muscle Wasting?

News

A research group at NTNU and several partners have identified a possible mechanism for how cancer cells may be sending messages to muscle cells resulting in cancer-related muscle wasting.

READ MORE

Psoriasis Drug Target Holds Potential for Bone Cancer

News

Researchers have discovered a potential therapeutic target for osteosarcoma – one which is already used to treat psoriasis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE